SCHEDULE: Alyeska Investment Group Discloses 5.51% Stake in Hinge Health

Alyeska Investment Group, L.P. and its affiliates have disclosed a beneficial ownership of 5.51% in Hinge Health, Inc.'s Class A Common Stock.

Summary

• Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh collectively reported beneficial ownership of 1,363,061 shares of Hinge Health, Inc.'s Class A Common Stock.
• This ownership represents 5.51% of the outstanding Class A Common Stock.
• The reporting persons hold shared voting power and shared dispositive power over all 1,363,061 shares.
• The percentage calculation is based on 24,749,541 outstanding shares of Common Stock, as reported by Hinge Health, Inc. in its 8-A12B filing on May 19, 2025.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: A Schedule 13G filing is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the company's performance or outlook. It is a neutral regulatory compliance document.

Future Outlook

NA

Industry Context

This filing is a standard disclosure of a significant ownership stake by an institutional investor in a publicly traded company within the healthcare technology sector. It reflects an investment decision by Alyeska Investment Group, a known hedge fund, in Hinge Health, Inc., a company focused on digital musculoskeletal care.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, potentially signaling institutional confidence or interest in the company.

Key Dates

Keywords

Hinge Health, Alyeska Investment Group, Beneficial Ownership, Class A Common Stock, SEC Filing, Investment Adviser, Healthcare Technology